Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease

Type 2 diabetes (T2D) and metabolic (dysfunction)-associated steatotic liver disease (MASLD) affect a growing number of individuals worldwide. T2D and MASLD often coexist and substantially elevate the risk of adverse hepatic and cardiovascular clinical outcomes. Several common pathogenetic mechanism...

Descripció completa

Dades bibliogràfiques

Autors principals:	Daniela Ciobârcă, Adriana Florinela Cătoi, Laura Gavrilaș, Roxana Banc, Doina Miere, Lorena Filip
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2025-02-01
Col·lecció:	Pharmaceuticals
Matèries:	type 2 diabetes metabolic (dysfunction)-associated steatotic liver disease non-alcoholic fatty liver disease gut dysbiosis natural bioactive compounds berberine
Accés en línia:	https://www.mdpi.com/1424-8247/18/2/279
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!